Insider Transactions in Q2 2021 at Supernus Pharmaceuticals, Inc. (SUPN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 14
2021
|
Tami Tillotson Martin Sr. V.P., Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
3,125
-3.49%
|
$96,875
$31.98 P/Share
|
|
Apr 14
2021
|
Tami Tillotson Martin Sr. V.P., Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+3.38%
|
$37,500
$12.98 P/Share
|
|
Apr 13
2021
|
Tami Tillotson Martin Sr. V.P., Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
3,125
-3.49%
|
$90,625
$29.98 P/Share
|
|
Apr 13
2021
|
Tami Tillotson Martin Sr. V.P., Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+3.38%
|
$37,500
$12.98 P/Share
|